3rd Quarter - Report
KEVIN MCGUINESS PLLC for TEVA PHARMACEUTICALS USA INC.
Firm
Income
$25,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 214, the Preserve Access to Affordable Generics Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.